A team from the Hong Kong University of Science and Technology (HKUST) has recently developed a new technology that could increase synthetic mRNA’s protein production efficiency, thereby strengthening the efficiency of cancer treatments and COVID-19 vaccines.
The finding was recently published in the online version of the journal Molecular Therapy—Nucleic Acids.
